2-Methoxyestradiol inhibits progesterone-dependent tissue factor expression and activity in breast cancer cells
link https://doi.org/10.1007/s12672-010-0019-5account_box Quezada, M.account_box Diaz, J.account_box Henriquez, S.account_box Bravo Castillo, María Loretoaccount_box Aranda, E.account_box Oliva, B.account_box Villalón, Manuel J.account_box Kato Cardemil, Sumie Rodeaccount_box Cuello F., Mauricioaccount_box Brosens, J. J.account_box Lange, C. A.account_box Owen, Gareth Ivor
Comparte este registro
2-Methoxyestradiol (2ME) is an endogenous metabolite of 17β-estradiol with antiangiogenic and antitumor properties, although its mechanisms of action remain unclear. Progestins in hormone replacement therapy increase the risk of breast cancer. Progesteron
Registro Sencillo
Registro Completo
| Autor | Quezada, M. Diaz, J. Henriquez, S. Bravo Castillo, María Loreto Aranda, E. Oliva, B. Villalón, Manuel J. Kato Cardemil, Sumie Rode Cuello F., Mauricio Brosens, J. J. Lange, C. A. Owen, Gareth Ivor |
| Título | 2-Methoxyestradiol inhibits progesterone-dependent tissue factor expression and activity in breast cancer cells |
| Revista | Hormones and Cancer |
| Volumen | Vol. 1 |
| Número de publicación | No. 3 |
| Página inicio | 117 |
| Página final | 126 |
| Fecha de publicación | 2010 |
| Resumen | 2-Methoxyestradiol (2ME) is an endogenous metabolite of 17β-estradiol with antiangiogenic and antitumor properties, although its mechanisms of action remain unclear. Progestins in hormone replacement therapy increase the risk of breast cancer. Progesteron |
| Derechos | acceso abierto |
| DOI | 10.1007/s12672-010-0019-5 |
| Enlace | |
| Paginación | 10 páginas |
| Palabra clave | 2-Methoxyestradiol Breast cancer Progesterone receptor STAT5 Tissue factor |
| Temática | Medicina y salud |
| Tipo de documento | artículo |